Clinical Trial Update: Inhaled Nitric Oxide to Prevent and Treat Bronchopulmonary Dysplasia [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/Phase 3 clinical trial evaluating inhaled nitric oxide for prevention and treatment of bronchopulmonary dysplasia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchopulmonary Dysplasia

Drugs mentioned

• Inhaled nitric oxide (nitric oxide)

Snippet

Sponsor: Fudan University | Conditions: Pulmonary Disease | Phase 2, Phase 3 | Status: COMPLETED